University of Minnesota. Driven to Discover.
(CIDRAP News) GlaxoSmithKline (GSK) promised today to give 50 million doses of its H5N1 "prepandemic" influenza vaccine to the World Health Organization (WHO) for distribution to poor countries.
The vaccine will be delivered over 3 years and be enough to vaccinate 25 million people at two doses each, the United Kingdombased drug company said in a news release.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.